Fertility and Sterility
Volume 93, Issue 7 , Pages 2175-2181 , 1 May 2010

Cumulative pregnancy probabilities among couples with subfertility: effects of varying treatments

Presented at the 21st Annual Meeting of the Society for Pediatric and Perinatal Epidemiologic Research, Chicago, Illinois, June 23–24, 2008.

  • Joseph B. Stanford, M.D.

      Affiliations

    • Department of Family and Preventive Medicine, Division of Public Health, University of Utah, Salt Lake City, Utah
    • ,
  • Rafael T. Mikolajczyk, M.D.

      Affiliations

    • Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Rockville, Maryland
    • Department of Public Health Medicine, University of Bielefeld, Bielefeld, Germany
    • Corresponding Author InformationReprint requests: Rafael Mikolajczyk, M.D., Department of Public Health Medicine, School of Public Health, University of Bielefeld, P.O. Box 100131, D-33501 Bielefeld, Germany (FAX: +49 (0)521 106-2968).
    • ,
  • Courtney D. Lynch, Ph.D.

      Affiliations

    • Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Rockville, Maryland
    • Division of Epidemiology, Ohio State University College of Public Health, Columbus, Ohio
    • ,
  • Sara E. Simonsen, M.S.P.H.

      Affiliations

    • Department of Family and Preventive Medicine, Division of Public Health, University of Utah, Salt Lake City, Utah

Received 15 December 2008 ,Revised 6 January 2009 ,Accepted 9 January 2009.

References 

  1. American Society for Reproductive Medicine. Definition of “infertility”. Fertil Steril. 2004;82:206
  2. Oakley L, Doyle P, Maconochie N. Lifetime prevalence of infertility and infertility treatment in the UK: results from a population-based survey of reproduction. Hum Reprod. 2008;23:447–450
  3. Evers JL. Female subfertility. Lancet. 2002;360:151–159
  4. Guzick DS, Grefenstette I, Baffone K, Berga SL, Krasnow JS, Stovall DW, et al. Infertility evaluation in fertile women: a model for assessing the efficacy of infertility testing. Hum Reprod. 1994;9:2306–2310
  5. Goverde AJ, McDonnell J, Vermeiden JP, Schats R, Rutten FF, Schoemaker J. Intrauterine insemination or in-vitro fertilisation in idiopathic subfertility and male subfertility: a randomised trial and cost-effectiveness analysis. Lancet. 2000;355:13–18
  6. Guzick DS, Sullivan MW, Adamson GD, Cedars MI, Falk RJ, Peterson EP, et al. Efficacy of treatment for unexplained infertility. Fertil Steril. 1998;70:207–213
  7. Guzick DS, Overstreet JW, Factor-Litvak P, Brazil CK, Nakajima ST, Coutifaris C, et al. Sperm morphology, motility, and concentration in fertile and infertile men. N Engl J Med. 2001;345:1388–1393
  8. Hunault CC, Habbema JD, Eijkemans MJ, Collins JL, Evers JL. Two new prediction rules for spontaneous pregnancy leading to live births among subfertile couples, based on the synthesis of three previous models. Hum Reprod. 2004;19:2019–2026
  9. Crosignani PG, Rubin BL ESHRE Capri Workshop Group. Optimal use of infertility diagnostic tests and treatments. Hum Reprod. 2000;15:723–732
  10. Adamson GD, Baker VL. Subfertility: causes, treatment and outcome. Best Pract Res Clin Obstet Gynaecol. 2003;17:169–185
  11. Guzick DS, Carson SA, Coutifaris C, Overstreet JW, Factor-Litvak P, Steinkampf MP, et al. Efficacy of superovulation and intrauterine insemination in the treatment of infertility. N Engl J Med. 1999;340:177–183
  12. Peterson CM, Hatasaka HH, Jones KP, Poulson AM, Carrell DT, Urry RL. Ovulation induction with gonadotropins and intrauterine insemination compared with in vitro fertilization and no therapy: a prospective, nonrandomized, cohort study and meta-analysis. Fertil Steril. 1994;62:535–544
  13. Crosignani PG, Walters DE, Soliani A European Society of Human Reproduction and Embryology. The ESHRE multicentre trial on the treatment of unexplained infertility: a preliminary report. Hum Reprod. 1991;6:953–958
  14. Athaullah N, Proctor M, Johnson NP. Oral versus injectable ovulation induction agents for unexplained subfertility. Cochrane Database Syst Rev. 2002;CD003052
  15. Verhulst SM, Cohlen BJ, Hughes E, Heineman MJ, Te Velde E. Intra-uterine insemination for unexplained subfertility (protocol). Cochrane Database Syst Rev. 2005;4
  16. Pandian Z, Bhattacharya S, Vale L, Templeton A. In vitro fertilisation for unexplained subfertility. Cochrane Database Syst Rev. 2005;CD003357
  17. Hughes E, Collins J, Vandekerckhove P. Clomiphene citrate for unexplained subfertility in women. Cochrane Database Syst Rev. 2000;CD000057
  18. American Society for Reproductive Medicine. Effectiveness and treatment for unexplained infertility. Fertil Steril. 2006;86:S111–S114
  19. Barlow DH. The design, publication and interpretation of research in subfertility medicine: uncomfortable issues and challenges to be faced. Hum Reprod. 2003;18:899–901
  20. Daya S. Pitfalls in the design and analysis of efficacy trials in subfertility. Hum Reprod. 2003;18:1005–1009
  21. te Velde ER, Eijkemans R, Habbema HD. Variation in couple fecundity and time to pregnancy, an essential concept in human reproduction. Lancet. 2000;355:1928–1929
  22. Gleicher N, Weghofer A, Barad D. A formal comparison of the practice of assisted reproductive technologies between Europe and the USA. Hum Reprod. 2006;21:1945–1950
  23. American Society for Reproductive Medicine. Assisted reproductive technology in the United States: 2001 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology registry. Fertil Steril. 2007;87:1253–1266
  24. Aboulghar MA, Mansour RT, Serour GI, Al-Inany HG. Diagnosis and management of unexplained infertility: an update. Arch Gynecol Obstet. 2003;267:177–188
  25. Pashayan N, Lyratzopoulos G, Mathur R. Cost-effectiveness of primary offer of IVF vs. primary offer of IUI followed by IVF (for IUI failures) in couples with unexplained or mild male factor subfertility. BMC Health Serv Res. 2006;6:80
  26. Ecochard R. Heterogeneity in fecundability studies: issues and modelling. Stat Methods Med Res. 2006;15:141–160
  27. Weinberg CR, Gladen BC. The beta-geometric distribution applied to comparative fecundability studies. Biometrics. 1986;42:547–560
  28. Ellish NJ, Saboda K, O'Connor J, Nasca PC, Stanek EJ, Boyle C. A prospective study of early pregnancy loss. Hum Reprod. 1996;11:406–412
  29. Bonde JP, Hjollund NH, Jensen TK, Ernst E, Kolstad H, Henriksen TB, et al. A follow-up study of environmental and biologic determinants of fertility among 430 Danish first-pregnancy planners: design and methods. Reprod Toxicol. 1998;12:19–27
  30. Buck GM, Lynch CD, Stanford JB, Sweeney AM, Schieve LA, Rockett JC, et al. Prospective pregnancy study designs for assessing reproductive and developmental toxicants. Environ Health Perspect. 2004;112:79–86
  31. Gnoth C, Godehardt D, Godehardt E, Frank-Herrmann P, Freundl G. Time to pregnancy: results of the German prospective study and impact on the management of infertility. Hum Reprod. 2003;18:1959–1966
  32. Zinaman MJ, Clegg ED, Brown CC, O'Connor J, Selevan SG. Estimates of human fertility and pregnancy loss. Fertil Steril. 1996;65:503–509
  33. Dunson DB, Baird DD, Colombo B. Increased infertility with age in men and women. Obstet Gynecol. 2004;103:51–56
  34. Larsen U. Research on infertility: which definition should we use?. Fertil Steril. 2005;83:846–852
  35. Rowe PJ World Health Organization. WHO manual for the standardized investigation and diagnosis of the infertile couple. Cambridge and New York: Cambridge University Press; 1993;
  36. Silverberg K, Daya S, Auray JP, Duru G, Ledger W, Wikland M, et al. Analysis of the cost effectiveness of recombinant versus urinary follicle-stimulating hormone in in vitro fertilization/intracytoplasmic sperm injection programs in the United States. Fertil Steril. 2002;77:107–113
  37. Gnoth C, Frank-Herrmann P, Freundl G. Opinion: natural family planning and the management of infertility. Arch Gynecol Obstet. 2002;267:67–71
  38. Stanford JB, Dunson DB. Effects of sexual intercourse patterns in time to pregnancy studies. Am J Epidemiol. 2007;165:1688–1695
  39. National Collaborating Centre for Women's and Children's Health (United Kingdom). Fertility assessment and treatment for people with fertility problems. In: National Institute for Clinical Excellence. London: Royal College of Obstetricians and Gynaecologists Press; 2004;
  40. Lintsen AM, Eijkemans MJ, Hunault CC, Bouwmans CA, Hakkaart L, Habbema JD, et al. Predicting ongoing pregnancy chances after IVF and ICSI: a national prospective study. Hum Reprod. 2007;22:2455–2462
  41. Snick HK, Snick TS, Evers JL, Collins JA. The spontaneous pregnancy prognosis in untreated subfertile couples: the Walcheren primary care study. Hum Reprod. 1997;12:1582–1588
  42. van der Steeg JW, Steures P, Eijkemans MJ, Habbema JD, Hompes PG, Broekmans FJ, et al. Pregnancy is predictable: a large-scale prospective external validation of the prediction of spontaneous pregnancy in subfertile couples. Hum Reprod. 2007;22:536–542
  43. Collins JA, Burrows EA, Wilan AR. The prognosis for live birth among untreated infertile couples. Fertil Steril. 1995;64:22–28
  44. Eijkemans MJC, Lintsen AME, Hunault CC, Bouwmans CAM, Hakkaart L, Braat DDM, et al. Pregnancy chances on an IVF/ICSI waiting list: a national prospective cohort study. Hum Reprod. 2008;23:1627–1632
  45. Tan SL, Royston P, Campbell S, Jacobs HS, Betts J, Mason B, et al. Cumulative conception and livebirth rates after in-vitro fertilisation. Lancet. 1992;339:1390–1394
  46. Stolwijk AM, Hamilton CJ, Hollanders JM, Bastiaans LA, Zielhuis GA. A more realistic approach to the cumulative pregnancy rate after in-vitro fertilization. Hum Reprod. 1996;11:660–663
  47. Stolwijk AM, Wetzels AM, Braat DD. Cumulative probability of achieving an ongoing pregnancy after in-vitro fertilization and intracytoplasmic sperm injection according to a woman's age, subfertility diagnosis and primary or secondary subfertility. Hum Reprod. 2000;15:203–209
  48. Cohlen BJ, Vandekerckhove P, te Velde ER, Habbema JD. Timed intercourse versus intra-uterine insemination with or without ovarian hyperstimulation for subfertility in men. Cochrane Database Syst Rev. 2000;CD000360
  49. Bhattacharya S, Harrild K, Mollison J, Wordsworth S, Tay C, Harrold A, et al. Clomifene citrate or unstimulated intrauterine insemination compared with expectant management for unexplained infertility: pragmatic randomised controlled trial. BMJ. 2008;337:a716
  50. Stanford JB, Parnell TA, Boyle PC. Outcomes from treatment of infertility with natural procreative technology in an Irish general practice. J Am Board Fam Med. 2008;21:375–384
  51. Jacobson TZ, Barlow DH, Koninckx PR, Olive D, Farquhar C. Laparoscopic surgery for subfertility associated with endometriosis. Cochrane Database Syst Rev. 2002;
  52. Farquhar CM. The role of ovarian surgery in polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol. 2004;18:789–802
  53. Wilcox AJ, Dunson D, Baird DD. The timing of the “fertile window” in the menstrual cycle: day specific estimates from a prospective study. Br Med J. 2000;321:1259–1262
  54. Stanford JB, White GL, Hatasaka H. Timing intercourse to achieve pregnancy: current evidence. Obstet Gynecol. 2002;100:1333–1341
  55. Keulers MJ, Hamilton CJCM, Franx A, Evers JLH, Bots RSGM. The length of the fertile window is associated with the chance of spontaneously conceiving an ongoing pregnancy in subfertile couples. Hum Reprod. 2007;22:1652–1656
  56. Stanford JB, Smith KR, Dunson DB. Vulvar mucus observations and the probability of pregnancy. Obstet Gynecol. 2003;101:1285–1293
  57. Robinson JE, Wakelin M, Ellis JE. Increased pregnancy rate with use of the Clearblue Easy Fertility Monitor. Fertil Steril. 2007;87:329–334
  58. Bigelow JL, Dunson DB, Stanford JB, Ecochard R, Gnoth C, Colombo B. Mucus observations in the fertile window: a better predictor of conception than timing of intercourse. Hum Reprod. 2004;19:889–892
  59. Leridon H. A new estimate of permanent sterility by age: sterility defined as the inability to conceive. Popul Stud (Camb). 2008;62:15–24
  60. Leridon H. Can assisted reproduction technology compensate for the natural decline in fertility with age? A model assessment. Hum Reprod. 2004;19:1548–1553
  61. American Society for Reproductive Medicine. Optimal evaluation of the infertile female. Fertil Steril. 2004;82:169–172
  62. American Society for Reproductive Medicine. Report on optimal evaluation of the infertile male. Fertil Steril. 2004;82:123–130
  63. American Society for Reproductive Medicine. Aging and infertility in women. Fertil Steril. 2004;82:102–106
  64. Van Voorhis BJ. Outcomes from assisted reproductive technology. Obstet Gynecol. 2006;107:183–200

 J.S. has nothing to disclose. R.M. has nothing to disclose. C.L. has nothing to disclose. S.S. has nothing to disclose.

 Supported by Eunice Kennedy Shriver National Institute of Child Health and Human Development Intramural Research Program, National Institutes of Health, Bethesda, Maryland.

PII: S0015-0282(09)00137-X

doi: 10.1016/j.fertnstert.2009.01.080

Fertility and Sterility
Volume 93, Issue 7 , Pages 2175-2181 , 1 May 2010

Article Tools

* Image Usage & Resolution